Insmed Inc

Research Insmed Inc (INSM) on Bullrun: market cap USD 22.70B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerINSM
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 22.70B
• Financial periodFY2025
• RevenueUSD 606.42M
• Revenue growth66.7%
• Net income-USD 1.28B
• Free cash flow-USD 967.58M
• Gross margin79.7%

Valuation Snapshot

latest market cap is USD 22.70B.

About Insmed Inc

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients.

Frequently asked questions

What is Insmed Inc's market cap?

Insmed Inc's market capitalization is USD 22.70B.

What does Insmed Inc do?

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.